Tasuku Honjo

Kyoto, Japan

Tasuku Honjo

Nobel Prize
USPTO Granted Patents = 40 

 

 

Average Co-Inventor Count = 3.1

ph-index = 19

Forward Citations = 1,882(Granted Patents)


Location History:

  • Toyonaka, JP (1989 - 1994)
  • Toyonaka-shi, Osaka, SE (1995)
  • Osaka, JP (1996)
  • Sakyo-ku, Kyoto, Kyoto, JP (1996)
  • Sakyo-ku, Kyoto, JP (2008)
  • Kyoto-shi, Kyoto, JP (2007 - 2010)
  • Kyoto, JP (1996 - 2023)

Company Filing History:


Years Active: 1989-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
PD-1 Signal Inhibitor
Immunopotentiative Composition
Anti-PD-L1 Antibody
Polypeptide ESDN
Stem Cell-Derived Neuron Factors
Cytidine Deaminase
Human Immunoglobulin VH Gene
B-Cell Differentiation Factor
Interleukin 2 Receptor
Cancer Treatment
Heart Disease Remedy Screening
40 patents (USPTO):Explore Patents

Title: Inventor Tasuku Honjo: Innovating Immune Therapy

Introduction

Tasuku Honjo, a renowned inventor and immunologist based in Kyoto, Japan, has made significant contributions to the field of immune therapy. With a remarkable portfolio of approximately 40 patents, Honjo's work primarily focuses on the mechanisms of immune response and treatment efficacy, notably in cancer therapy.

Latest Patents

Among his latest innovations is the patent for **"Efficacy determination markers in disease treatment by PD-1 signal inhibitor."** This invention provides critical markers for assessing the efficacy of therapy using PD-1 signal inhibitors. It utilizes biomarkers like metabolic changes in T cells and intestinal flora-related metabolites to predict therapeutic outcomes early in the treatment process. Another noteworthy patent is for a **"substance specific to human PD-1,"** which aims to enhance therapeutic interventions targeting diseases caused by immunopathy. This specialized substance functions by selectively recognizing human PD-1 and relevant membrane proteins, offering promising avenues for treatment and prevention.

Career Highlights

Throughout his impressive career, Tasuku Honjo has worked with notable organizations, including Ono Pharmaceutical Co., Ltd. His dedication to advancing immunology and therapeutic effectiveness has positioned him as a pivotal figure in medical research and innovation.

Collaborations

Honjo's work has also been enriched by collaborations with esteemed colleagues, such as Shiro Shibayama and Kei Tashiro. Together, they have contributed significantly to the understanding of immune mechanisms and potential therapeutic applications, further enhancing the impact of their combined expertise.

Conclusion

Tasuku Honjo's pioneering inventions and research in immunotherapy solidify his status as an influential inventor. His continuous pursuit of innovation in developing therapeutic markers and substances not only aids in disease treatment but also exemplifies the vital role of inventors in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…